{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T12:19:20Z","timestamp":1766924360189,"version":"3.48.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,28]]},"DOI":"10.7759\/cureus.100241","type":"journal-article","created":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T12:17:35Z","timestamp":1766924255000},"source":"Crossref","is-referenced-by-count":0,"title":["Early Diagnosis of Male Breast Cancer: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Jos\u00e9 Aderval","family":"Arag\u00e3o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Valdercides","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iapunira Catarina","family":"Sant\u2019Anna Arag\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Matheus","family":"Sant\u2019Anna Arag\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Prado","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01489-z","article-title":"Male breast cancer: a review on diagnosis, treatment, and survivorship","volume":"26","author":"Bhardwaj PV","year":"2024","unstructured":"Bhardwaj PV, Gupta S, Elyash A, Teplinsky E. Male breast cancer: a review on diagnosis, treatment, and survivorship. Curr Oncol Rep. 2024, 26:34-45. 10.1007\/s11912-023-01489-z","journal-title":"Curr Oncol Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1734049","article-title":"Male breast cancer: an updated review of epidemiology, clinicopathology, and treatment","volume":"2022","author":"Zheng G","year":"2022","unstructured":"Zheng G, Leone JP. Male breast cancer: an updated review of epidemiology, clinicopathology, and treatment. J Oncol. 2022, 2022:1734049. 10.1155\/2022\/1734049","journal-title":"J Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03190-7","article-title":"Male breast cancer: an update","volume":"480","author":"Fox S","year":"2022","unstructured":"Fox S, Speirs V, Shaaban AM. Male breast cancer: an update. Virchows Arch. 2022, 480:85-93. 10.1007\/s00428-021-03190-7","journal-title":"Virchows Arch"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-024-09560-6","article-title":"Exploring the one health paradigm in male breast cancer","volume":"29","author":"Tay KL","year":"2024","unstructured":"Tay KL, Cowan G, Chatterji S, Conti G, Speirs V. Exploring the one health paradigm in male breast cancer. J Mammary Gland Biol Neoplasia. 2024, 29:8. 10.1007\/s10911-024-09560-6","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10558-4","article-title":"Clinical aspect of male breast cancer: a burgeoning and unaddressed issue","volume":"52","author":"Ray SK","year":"2025","unstructured":"Ray SK, Mukherjee S. Clinical aspect of male breast cancer: a burgeoning and unaddressed issue. Mol Biol Rep. 2025, 52:452. 10.1007\/s11033-025-10558-4","journal-title":"Mol Biol Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13299","article-title":"Male breast cancer in Australia","volume":"17","author":"Lomma C","year":"2021","unstructured":"Lomma C, Chan A, Chih H, Reid C, Peter W. Male breast cancer in Australia. Asia Pac J Clin Oncol. 2021, 17:e57-62. 10.1111\/ajco.13299","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14542","article-title":"Male triple-negative breast cancer","volume":"13","author":"Qavi Q","year":"2021","unstructured":"Qavi Q, Alkistawi F, Kumar S, Ahmed R, Saad Abdalla Al-Zawi A. Male triple-negative breast cancer. Cureus. 2021, 13:e14542. 10.7759\/cureus.14542","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djac241","article-title":"Survival in male breast cancer over the past 3 decades","volume":"115","author":"Leone JP","year":"2023","unstructured":"Leone JP, Freedman RA, Leone J, et al.. Survival in male breast cancer over the past 3 decades. J Natl Cancer Inst. 2023, 115:421-8. 10.1093\/jnci\/djac241","journal-title":"J Natl Cancer Inst"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02140-y","article-title":"Decoding male breast cancer: epidemiological insights, cutting-edge treatments, and future perspectives","volume":"16","author":"Zhao L","year":"2025","unstructured":"Zhao L, Cheng H, He D, Zhang Y, Chai Y, Song A, Sun G. Decoding male breast cancer: epidemiological insights, cutting-edge treatments, and future perspectives. Discov Oncol. 2025, 16:360. 10.1007\/s12672-025-02140-y","journal-title":"Discov Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20312","article-title":"Breast carcinoma in men: a population-based study","volume":"101","author":"Giordano SH","year":"2004","unstructured":"Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004, 101:51-7. 10.1002\/cncr.20312","journal-title":"Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx651","article-title":"Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG International Male Breast Cancer Program","volume":"29","author":"Cardoso F","year":"2018","unstructured":"Cardoso F, Bartlett JM, Slaets L, et al.. Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG International Male Breast Cancer Program. Ann Oncol. 2018, 29:405-17. 10.1093\/annonc\/mdx651","journal-title":"Ann Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05556-y","article-title":"Male breast cancer: a closer look at patient and tumor characteristics and factors that affect survival using the National Cancer Database","volume":"180","author":"Sarmiento S","year":"2020","unstructured":"Sarmiento S, McColl M, Musavi L, et al.. Male breast cancer: a closer look at patient and tumor characteristics and factors that affect survival using the National Cancer Database. Breast Cancer Res Treat. 2020, 180:471-9. 10.1007\/s10549-020-05556-y","journal-title":"Breast Cancer Res Treat"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0327-6","article-title":"Men with breast cancer have same disease-specific and event-free survival as women","volume":"16","author":"Marchal F","year":"2009","unstructured":"Marchal F, Salou M, Marchal C, Lesur A, Desandes E. Men with breast cancer have same disease-specific and event-free survival as women. Ann Surg Oncol. 2009, 16:972-8. 10.1245\/s10434-009-0327-6","journal-title":"Ann Surg Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08718-3","article-title":"Genetic predisposition to male breast cancer in Poland","volume":"21","author":"Szwiec M","year":"2021","unstructured":"Szwiec M, Tomiczek-Szwiec J, Klu\u017aniak W, et al.. Genetic predisposition to male breast cancer in Poland. BMC Cancer. 2021, 21:975. 10.1186\/s12885-021-08718-3","journal-title":"BMC Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-23-592","article-title":"Neoadjuvant treatment for male breast cancer","volume":"12","author":"Fentiman IS","year":"2023","unstructured":"Fentiman IS. Neoadjuvant treatment for male breast cancer. Transl Cancer Res. 2023, 12:1669-71. 10.21037\/tcr-23-592","journal-title":"Transl Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2025.0071","article-title":"Diseases of the male breast: gynecomastia and breast cancer","volume":"122","author":"Faridi A","year":"2025","unstructured":"Faridi A, Gerber B, Hartmann S. Diseases of the male breast: gynecomastia and breast cancer. Dtsch Arztebl Int. 2025, 122:406-11. 10.3238\/arztebl.m2025.0071","journal-title":"Dtsch Arztebl Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/9003572","article-title":"Male breast cancer: an updated review of patient characteristics, genetics, and outcome","volume":"2024","author":"Khare VS","year":"2024","unstructured":"Khare VS, Huda F, Misra S, Amulya KR, Raj N, Karn S, Basu S. Male breast cancer: an updated review of patient characteristics, genetics, and outcome. Int J Breast Cancer. 2024, 2024:9003572. 10.1155\/2024\/9003572","journal-title":"Int J Breast Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1148\/rg.230181","article-title":"Imaging the male breast: gynecomastia, male breast cancer, and beyond","volume":"44","author":"Mannix J","year":"2024","unstructured":"Mannix J, Duke H, Almajnooni A, Ongkeko M. Imaging the male breast: gynecomastia, male breast cancer, and beyond. Radiographics. 2024, 44:e230181. 10.1148\/rg.230181","journal-title":"Radiographics"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-021-06413-2","article-title":"Penetrance of male breast cancer susceptibility genes: a systematic review","volume":"191","author":"Chamseddine RS","year":"2022","unstructured":"Chamseddine RS, Wang C, Yin K, et al.. Penetrance of male breast cancer susceptibility genes: a systematic review. Breast Cancer Res Treat. 2022, 191:31-8. 10.1007\/s10549-021-06413-2","journal-title":"Breast Cancer Res Treat"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103827","article-title":"The incidence of male breast cancer in Klinefelter Syndrome and its proposed mechanisms","volume":"78","author":"Cook B","year":"2024","unstructured":"Cook B, Nayar S, Filson S, Yap T. The incidence of male breast cancer in Klinefelter Syndrome and its proposed mechanisms. Breast. 2024, 78:103827. 10.1016\/j.breast.2024.103827","journal-title":"Breast"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143535","article-title":"Genetic landscape of male breast cancer","volume":"13","author":"Campos FA","year":"2021","unstructured":"Campos FA, Rouleau E, Torrezan GT, et al.. Genetic landscape of male breast cancer. Cancers (Basel). 2021, 13:3535. 10.3390\/cancers13143535","journal-title":"Cancers (Basel)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2020.08.010","article-title":"Epidemiology of male breast cancer","volume":"54","author":"Konduri S","year":"2020","unstructured":"Konduri S, Singh M, Bobustuc G, Rovin R, Kassam A. Epidemiology of male breast cancer. Breast. 2020, 54:8-14. 10.1016\/j.breast.2020.08.010","journal-title":"Breast"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2174\/1871520623666230821124008","article-title":"Male breast cancer: three case reports and a literature review","volume":"23","author":"Xin Y","year":"2023","unstructured":"Xin Y, Wang F, Ren D, Zhao F, Zhao J. Male breast cancer: three case reports and a literature review. Anticancer Agents Med Chem. 2023, 23:2161-9. 10.2174\/1871520623666230821124008","journal-title":"Anticancer Agents Med Chem"},{"key":"ref24","article-title":"Male Breast Cancer Treatment (PDQ\u00ae): Health Professional Version","author":"PDQ Adult Treatment Editorial Board","year":"2002","unstructured":"PDQ Adult Treatment Editorial Board. Male Breast Cancer Treatment (PDQ\u00ae): Health Professional Version. PDQ Cancer Information Summaries. National Cancer Institute (US), Bethesda (MD); 2002."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103762","article-title":"The features of male breast cancer in China: a real-world study","volume":"76","author":"Gao Y","year":"2024","unstructured":"Gao Y, Zhang M, Sun G, et al.. The features of male breast cancer in China: a real-world study. Breast. 2024, 76:103762. 10.1016\/j.breast.2024.103762","journal-title":"Breast"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08267-9","article-title":"Poor prognosis of male triple-positive breast cancer patients: a propensity score matched SEER analysis and molecular portraits","volume":"21","author":"Wang B","year":"2021","unstructured":"Wang B, Wang H, Zhao A, Zhang M, Yang J. Poor prognosis of male triple-positive breast cancer patients: a propensity score matched SEER analysis and molecular portraits. BMC Cancer. 2021, 21:523. 10.1186\/s12885-021-08267-9","journal-title":"BMC Cancer"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41318-2","article-title":"Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer","volume":"14","author":"Sun H","year":"2023","unstructured":"Sun H, Zhang L, Wang Z, et al.. Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer. Nat Commun. 2023, 14:5590. 10.1038\/s41467-023-41318-2","journal-title":"Nat Commun"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt025","article-title":"Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship","volume":"24","author":"Ruddy KJ","year":"2013","unstructured":"Ruddy KJ, Winer EP. Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol. 2013, 24:1434-43. 10.1093\/annonc\/mdt025","journal-title":"Ann Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015449","article-title":"Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma","volume":"98","author":"Li JP","year":"2019","unstructured":"Li JP, Zhang XM, Zhang Z, Zheng LH, Jindal S, Liu YJ. Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma. Medicine (Baltimore). 2019, 98:e15449. 10.1097\/MD.0000000000015449","journal-title":"Medicine (Baltimore)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000110025","article-title":"Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis","volume":"74","author":"Andr\u00e9 S","year":"2007","unstructured":"Andr\u00e9 S, Pinto AE, Laranjeira C, Quaresma M, Soares J. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis. Pathobiology. 2007, 74:323-7. 10.1159\/000110025","journal-title":"Pathobiology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2022.07.022","article-title":"Involvement of the p53\/p21 complex in p53-dependent gene expression","volume":"621","author":"Kim U","year":"2022","unstructured":"Kim U, Kim KS, Park JK, Um HD. Involvement of the p53\/p21 complex in p53-dependent gene expression. Biochem Biophys Res Commun. 2022, 621:151-6. 10.1016\/j.bbrc.2022.07.022","journal-title":"Biochem Biophys Res Commun"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000678","article-title":"Adjuvant treatment of early male breast cancer","volume":"32","author":"Corti C","year":"2020","unstructured":"Corti C, Crimini E, Criscitiello C, Trapani D, Curigliano G. Adjuvant treatment of early male breast cancer. Curr Opin Oncol. 2020, 32:594-602. 10.1097\/CCO.0000000000000678","journal-title":"Curr Opin Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12071554","article-title":"An update on the general features of breast cancer in male patients: a literature review","volume":"12","author":"Ionescu S","year":"2022","unstructured":"Ionescu S, Nicolescu AC, Marincas M, Madge OL, Simion L. An update on the general features of breast cancer in male patients: a literature review. Diagnostics (Basel). 2022, 12:1554. 10.3390\/diagnostics12071554","journal-title":"Diagnostics (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2021.0828","article-title":"An introduction to male breast cancer for urologists: epidemiology, diagnosis, principles of treatment, and special situations","volume":"48","author":"Makdissi FB","year":"2022","unstructured":"Makdissi FB, Santos SS, Bitencourt A, Campos FA. An introduction to male breast cancer for urologists: epidemiology, diagnosis, principles of treatment, and special situations. Int Braz J Urol. 2022, 48:760-70. 10.1590\/S1677-5538.IBJU.2021.0828","journal-title":"Int Braz J Urol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2023.08.053","article-title":"Management of male patients with occult breast cancer: analysis of the National Cancer Database","volume":"293","author":"Wong WG","year":"2024","unstructured":"Wong WG, Perez Holguin RA, Kanwar R, Dodge D, Shen C. Management of male patients with occult breast cancer: analysis of the National Cancer Database. J Surg Res. 2024, 293:685-92. 10.1016\/j.jss.2023.08.053","journal-title":"J Surg Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2147\/BCTT.S516124","article-title":"Male breast cancer: evaluating the current landscape of diagnosis and treatment","volume":"17","author":"Ter-Zakarian A","year":"2025","unstructured":"Ter-Zakarian A, Agelidis A, Jaloudi M. Male breast cancer: evaluating the current landscape of diagnosis and treatment. Breast Cancer (Dove Med Press). 2025, 17:567-72. 10.2147\/BCTT.S516124","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.2185","article-title":"BRCA1, BRCA2, and associated cancer risks and management for male patients: a review","volume":"10","author":"Cheng HH","year":"2024","unstructured":"Cheng HH, Shevach JW, Castro E, et al.. BRCA1, BRCA2, and associated cancer risks and management for male patients: a review. JAMA Oncol. 2024, 10:1272-81. 10.1001\/jamaoncol.2024.2185","journal-title":"JAMA Oncol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33898","article-title":"Adjuvant tamoxifen adherence in male patients with breast cancer: an ongoing challenge","volume":"128","author":"Falkson CI","year":"2022","unstructured":"Falkson CI. Adjuvant tamoxifen adherence in male patients with breast cancer: an ongoing challenge. Cancer. 2022, 128:22-4. 10.1002\/cncr.33898","journal-title":"Cancer"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103694","article-title":"Stakeholders' experiences and perceptions of male breast cancer: a qualitative evidence synthesis","volume":"74","author":"Ye M","year":"2024","unstructured":"Ye M, Qiu L, Jin Y, Huang Y. Stakeholders' experiences and perceptions of male breast cancer: a qualitative evidence synthesis. Breast. 2024, 74:103694. 10.1016\/j.breast.2024.103694","journal-title":"Breast"},{"key":"ref40","article-title":"ACR BI-RADS\u00ae v2025 Manual","author":"Newell MS","year":"2025","unstructured":"Newell MS, Destounis SV, Leung JWT, DeMartini WB, Lee CH, Eby PR. ACR BI-RADS\u00ae v2025 Manual. American College of Radiology, Reston, VA; 2025."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2018-0378-CP","article-title":"Quantitative image analysis of human epidermal growth factor receptor 2 immunohistochemistry for breast cancer: guideline from the College of American Pathologists","volume":"143","author":"Bui MM","year":"2019","unstructured":"Bui MM, Riben MW, Allison KH, et al.. Quantitative image analysis of human epidermal growth factor receptor 2 immunohistochemistry for breast cancer: guideline from the College of American Pathologists. Arch Pathol Lab Med. 2019, 143:1180-95. 10.5858\/arpa.2018-0378-CP","journal-title":"Arch Pathol Lab Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik S","year":"2004","unstructured":"Paik S, Shak S, Tang G, et al . A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer . N Engl J Med. 2004, 351:2817-26. 10.1056\/NEJMoa041588","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/ans.17737","article-title":"Male breast cancer: a Singapore perspective","volume":"92","author":"Lim JS","year":"2022","unstructured":"Lim JS, Sim Y, Ngeow J, et al.. Male breast cancer: a Singapore perspective. ANZ J Surg. 2022, 92:1440-6. 10.1111\/ans.17737","journal-title":"ANZ J Surg"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.10.010","article-title":"A systematic review of seroma formation following drain-free mastectomy","volume":"47","author":"De Rooij L","year":"2021","unstructured":"De Rooij L, Bosmans JW, van Kuijk SM, Vissers YL, Beets GL, van Bastelaar J. A systematic review of seroma formation following drain-free mastectomy. Eur J Surg Oncol. 2021, 47:757-63. 10.1016\/j.ejso.2020.10.010","journal-title":"Eur J Surg Oncol"},{"key":"ref45","article-title":"Role of methylprednisolone in the prevention of seroma formation after mastectomy: a randomized controlled trial","volume":"60","author":"Subramanian P","year":"2023","unstructured":"Subramanian P, Arumugam M, Vaithianathan R. Role of methylprednisolone in the prevention of seroma formation after mastectomy: a randomized controlled trial. Indian J Cancer. 2023, 60:206-10.","journal-title":"Indian J Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/440859-early-diagnosis-of-male-breast-cancer-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T12:17:36Z","timestamp":1766924256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/440859-early-diagnosis-of-male-breast-cancer-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.100241","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,28]]}}}